HUSSMAN STRATEGIC ADVISORS, INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 202 filers reported holding SAGE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$255,192
-56.2%
12,4000.0%0.05%
-54.2%
Q2 2023$583,048
-46.6%
12,400
-52.3%
0.11%
-37.4%
Q1 2023$1,090,960
+10.0%
26,0000.0%0.17%
+5.6%
Q4 2022$991,640
-2.6%
26,0000.0%0.16%
-8.0%
Q3 2022$1,018,000
+21.2%
26,0000.0%0.18%
+21.4%
Q2 2022$840,000
-2.4%
26,0000.0%0.14%
-13.2%
Q1 2022$861,000
-22.2%
26,0000.0%0.17%
-31.3%
Q4 2021$1,106,000
-66.5%
26,000
-65.1%
0.24%
-66.6%
Q3 2021$3,297,000
-22.0%
74,4000.0%0.73%
-17.0%
Q2 2021$4,227,00074,4000.88%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders